Synovus Financial’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$376K Sell
2,096
-38
-2% -$6.47K ﹤0.01% 758
2025
Q2
$344K Buy
2,134
+778
+57% +$124K ﹤0.01% 758
2025
Q1
$231K Buy
+1,356
New +$235K ﹤0.01% 825
2024
Q4
Sell
-1,183
Closed -$203K 887
2024
Q3
$203K Buy
+1,183
New +$196K ﹤0.01% 872
2020
Q3
Sell
-221
Closed -$39K 925
2020
Q2
$39K Sell
221
-9,907
-98% -$1.55M ﹤0.01% 954
2020
Q1
$1.32M Buy
10,128
+9,525
+1,580% +$1.36M 0.02% 323
2019
Q4
$89K Buy
+603
New +$82.8K ﹤0.01% 829
2017
Q3
Sell
-600
Closed -$68K 620
2017
Q2
$68K Buy
+600
New +$64.5K ﹤0.01% 647

Other funds holding FBT

Synovus Financial's FBT Position: Q3 2025 in Review

Synovus Financial reduced its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 1.8% in Q3 2025, selling an estimated $6.47K and leaving 2,096 shares worth $376K. The position accounts for ﹤0.01% of the portfolio, ranked #758.

Synovus Financial first reported a position in FBT in Q2 2017 and has held it in 8 quarters since. The position peaked at $1.32M in Q1 2020. 253 funds tracked by Wall St. Rank hold FBT as of Q3 2025.

  • Synovus Financial held 2,096 shares of First Trust NYSE Arca Biotechnology Index Fund worth $376K as of Q3 2025.
  • Synovus Financial sold 38 First Trust NYSE Arca Biotechnology Index Fund shares in Q3 2025, an estimated $6.47K.
  • First Trust NYSE Arca Biotechnology Index Fund made up ﹤0.01% of Synovus Financial's portfolio in Q3 2025, its #758 holding.
  • Synovus Financial first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q2 2017 and has held it in 8 quarters since.
  • Synovus Financial's First Trust NYSE Arca Biotechnology Index Fund position peaked at $1.32M in Q1 2020.
  • 253 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q3 2025.

Based on Synovus Financial's 13F filing for Q3 2025, filed 7 Nov 2025.